The following is a list of "hot" genes: those that have been most frequently requested at the GeneCards home site since September 01, 2013 sorted by frequency of access.

  1. GGH gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
  2. FGG fibrinogen gamma chain
  3. TP53 tumor protein p53
  4. MYC v-myc avian myelocytomatosis viral oncogene homolog
  5. TUBA8 tubulin, alpha 8
  6. BRCA1 breast cancer 1, early onset
  7. JUN jun proto-oncogene
  8. EGFR epidermal growth factor receptor
  9. GAPDH glyceraldehyde-3-phosphate dehydrogenase
  10. ERBB2 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
  11. CDKN2A cyclin-dependent kinase inhibitor 2A
  12. TUBE1 tubulin, epsilon 1
  13. TNFRSF10B tumor necrosis factor receptor superfamily, member 10b
  14. BCL2 B-cell CLL/lymphoma 2
  15. PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
  16. MATK megakaryocyte-associated tyrosine kinase
  17. HTT huntingtin
  18. KRAS Kirsten rat sarcoma viral oncogene homolog
  19. CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa
  20. TNF tumor necrosis factor
  21. PTEN phosphatase and tensin homolog
  22. HBB hemoglobin, beta
  23. AKT1 v-akt murine thymoma viral oncogene homolog 1
  24. ESR1 estrogen receptor 1
  25. CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1)
  26. CCND1 cyclin D1
  27. ACTB actin, beta
  28. NXN nucleoredoxin
  29. FOS FBJ murine osteosarcoma viral oncogene homolog
  30. KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
  31. RB1 retinoblastoma 1
  32. TTN titin
  33. MET met proto-oncogene
  34. SIRT1 sirtuin 1
  35. FUK fucokinase
  36. AR androgen receptor
  37. HGF hepatocyte growth factor (hepapoietin A; scatter factor)
  38. IGF1 insulin-like growth factor 1 (somatomedin C)
  39. IL6 interleukin 6 (interferon, beta 2)
  40. PPARG peroxisome proliferator-activated receptor gamma
  41. CFTR cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
  42. ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
  43. BRAF v-raf murine sarcoma viral oncogene homolog B
  44. MTHFR methylenetetrahydrofolate reductase (NAD(P)H)
  45. CD44 CD44 molecule (Indian blood group)
  46. NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  47. FLT3 fms-related tyrosine kinase 3
  48. SOX2 SRY (sex determining region Y)-box 2
  49. MTOR mechanistic target of rapamycin (serine/threonine kinase)
  50. TGFB1 transforming growth factor, beta 1
  51. ATM ataxia telangiectasia mutated
  52. CDH1 cadherin 1, type 1, E-cadherin (epithelial)
  53. NOTCH1 notch 1
  54. APC adenomatous polyposis coli
  55. HPRT1 hypoxanthine phosphoribosyltransferase 1
  56. APOE apolipoprotein E
  57. STAT3 signal transducer and activator of transcription 3 (acute-phase response factor)
  58. GDF11 growth differentiation factor 11
  59. MDM2 MDM2 oncogene, E3 ubiquitin protein ligase
  60. EZH2 enhancer of zeste homolog 2 (Drosophila)
  61. VEGFA vascular endothelial growth factor A
  62. HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
  63. BRCA2 breast cancer 2, early onset
  64. IL8 interleukin 8
  65. TF transferrin
  66. KDR kinase insert domain receptor (a type III receptor tyrosine kinase)
  67. UBC ubiquitin C
  68. SRY sex determining region Y
  69. NF1 neurofibromin 1
  70. BAX BCL2-associated X protein
  71. SPP1 secreted phosphoprotein 1
  72. MAOA monoamine oxidase A
  73. POU5F1 POU class 5 homeobox 1
  74. VDR vitamin D (1,25- dihydroxyvitamin D3) receptor
  75. PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
  76. BDNF brain-derived neurotrophic factor
  77. HGD homogentisate 1,2-dioxygenase
  78. RUNX1 runt-related transcription factor 1
  79. EGR1 early growth response 1
  80. SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
  81. CCL2 chemokine (C-C motif) ligand 2
  82. NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
  83. APP amyloid beta (A4) precursor protein
  84. RAB19 RAB19, member RAS oncogene family
  85. RORA RAR-related orphan receptor A
  86. TERT telomerase reverse transcriptase
  87. GATA3 GATA binding protein 3
  88. SP1 Sp1 transcription factor
  89. CXCR4 chemokine (C-X-C motif) receptor 4
  90. SMAD4 SMAD family member 4
  91. COL1A1 collagen, type I, alpha 1
  92. MAPK1 mitogen-activated protein kinase 1
  93. FN1 fibronectin 1
  94. SRC v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog
  95. NRAS neuroblastoma RAS viral (v-ras) oncogene homolog
  96. TET2 tet methylcytosine dioxygenase 2
  97. JAK2 Janus kinase 2
  98. COMT catechol-O-methyltransferase
  99. ABL1 c-abl oncogene 1, non-receptor tyrosine kinase
  100. ALK anaplastic lymphoma receptor tyrosine kinase
  101. STAT1 signal transducer and activator of transcription 1, 91kDa
  102. NFE2L2 nuclear factor, erythroid 2-like 2
  103. IL1B interleukin 1, beta
  104. LMNA lamin A/C
  105. FOXP2 forkhead box P2
  106. SLC6A4 solute carrier family 6 (neurotransmitter transporter), member 4
  107. EP300 E1A binding protein p300
  108. NANOG Nanog homeobox
  109. HSPA5 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
  110. TET1 tet methylcytosine dioxygenase 1
  111. RET ret proto-oncogene
  112. ZEB1 zinc finger E-box binding homeobox 1
  113. CXCL12 chemokine (C-X-C motif) ligand 12
  114. REST RE1-silencing transcription factor
  115. CEBPA CCAAT/enhancer binding protein (C/EBP), alpha
  116. PAX6 paired box 6
  117. BCL2L1 BCL2-like 1
  118. BIRC5 baculoviral IAP repeat containing 5
  119. FAS Fas cell surface death receptor
  120. FOXO1 forkhead box O1
  121. PDGFRA platelet-derived growth factor receptor, alpha polypeptide
  122. SOD1 superoxide dismutase 1, soluble
  123. MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
  124. ETS1 v-ets avian erythroblastosis virus E26 oncogene homolog 1
  125. DDIT3 DNA-damage-inducible transcript 3
  126. SOX9 SRY (sex determining region Y)-box 9
  127. DCN decorin
  128. VIM vimentin
  129. NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
  130. PPARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
  131. CD274 CD274 molecule
  132. GNAS GNAS complex locus
  133. FGFR3 fibroblast growth factor receptor 3
  134. KLF4 Kruppel-like factor 4 (gut)
  135. E2F1 E2F transcription factor 1
  136. MCL1 myeloid cell leukemia 1
  137. SMAD3 SMAD family member 3
  138. DNMT1 DNA (cytosine-5-)-methyltransferase 1
  139. DMD dystrophin
  140. ACE angiotensin I converting enzyme
  141. CD36 CD36 molecule (thrombospondin receptor)
  142. NOS2 nitric oxide synthase 2, inducible
  143. MLH1 mutL homolog 1
  144. CREBBP CREB binding protein
  145. SNCA synuclein, alpha (non A4 component of amyloid precursor)
  146. PRKDC protein kinase, DNA-activated, catalytic polypeptide
  147. GATA1 GATA binding protein 1 (globin transcription factor 1)
  148. MAPT microtubule-associated protein tau
  149. LPP LIM domain containing preferred translocation partner in lipoma
  150. CEBPB CCAAT/enhancer binding protein (C/EBP), beta
  151. YAP1 Yes-associated protein 1
  152. IGF2 insulin-like growth factor 2 (somatomedin A)
  153. SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
  154. TBP TATA box binding protein
  155. FOXO3 forkhead box O3
  156. B2M beta-2-microglobulin
  157. BCL2L11 BCL2-like 11 (apoptosis facilitator)
  158. RELA v-rel avian reticuloendotheliosis viral oncogene homolog A
  159. SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
  160. FGFR1 fibroblast growth factor receptor 1
  161. TCF3 transcription factor 3
  162. CALR calreticulin
  163. MYB v-myb avian myeloblastosis viral oncogene homolog
  164. MYCN v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
  165. MAPK14 mitogen-activated protein kinase 14
  166. CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6
  167. G6PD glucose-6-phosphate dehydrogenase
  168. MGMT O-6-methylguanine-DNA methyltransferase
  169. HNF1A HNF1 homeobox A
  170. CD24 CD24 molecule
  171. CCR5 chemokine (C-C motif) receptor 5 (gene/pseudogene)
  172. FBN1 fibrillin 1
  173. PAPPA pregnancy-associated plasma protein A, pappalysin 1
  174. BCL6 B-cell CLL/lymphoma 6
  175. PARP1 poly (ADP-ribose) polymerase 1
  176. SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1
  177. PCNA proliferating cell nuclear antigen
  178. IGF1R insulin-like growth factor 1 receptor
  179. RAF1 v-raf-1 murine leukemia viral oncogene homolog 1
  180. MAPK3 mitogen-activated protein kinase 3
  181. TWIST1 twist family bHLH transcription factor 1
  182. WT1 Wilms tumor 1
  183. CREB1 cAMP responsive element binding protein 1
  184. DRD2 dopamine receptor D2
  185. PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  186. GATA2 GATA binding protein 2
  187. ARID1A AT rich interactive domain 1A (SWI-like)
  188. KDM6A lysine (K)-specific demethylase 6A
  189. MKI67 marker of proliferation Ki-67
  190. DNMT3A DNA (cytosine-5-)-methyltransferase 3 alpha
  191. AHR aryl hydrocarbon receptor
  192. ACTA2 actin, alpha 2, smooth muscle, aorta
  193. TCF4 transcription factor 4
  194. NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin)
  195. FLT1 fms-related tyrosine kinase 1
  196. HNF4A hepatocyte nuclear factor 4, alpha
  197. IDH1 isocitrate dehydrogenase 1 (NADP+), soluble
  198. STK11 serine/threonine kinase 11
  199. VHL von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
  200. NOS3 nitric oxide synthase 3 (endothelial cell)
  201. CDK1 cyclin-dependent kinase 1
  202. DRD4 dopamine receptor D4
  203. GSK3B glycogen synthase kinase 3 beta
  204. ADAR adenosine deaminase, RNA-specific
  205. HMOX1 heme oxygenase (decycling) 1
  206. SNAI1 snail family zinc finger 1
  207. LDLR low density lipoprotein receptor
  208. INS insulin
  209. KMT2C lysine (K)-specific methyltransferase 2C
  210. TNFAIP3 tumor necrosis factor, alpha-induced protein 3
  211. FGFR2 fibroblast growth factor receptor 2
  212. SKA2 spindle and kinetochore associated complex subunit 2
  213. MAFA v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
  214. FTO fat mass and obesity associated
  215. YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
  216. IL10 interleukin 10
  217. MECP2 methyl CpG binding protein 2 (Rett syndrome)
  218. RAC1 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
  219. ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
  220. ALB albumin
  221. OPRM1 opioid receptor, mu 1
  222. CTCF CCCTC-binding factor (zinc finger protein)
  223. AURKA aurora kinase A
  224. SOD2 superoxide dismutase 2, mitochondrial
  225. LEF1 lymphoid enhancer-binding factor 1
  226. CXCL10 chemokine (C-X-C motif) ligand 10
  227. ELAVL1 ELAV like RNA binding protein 1
  228. MAP2K1 mitogen-activated protein kinase kinase 1
  229. KMT2D lysine (K)-specific methyltransferase 2D
  230. EPCAM epithelial cell adhesion molecule
  231. THBS1 thrombospondin 1
  232. CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1)
  233. BMI1 BMI1 polycomb ring finger oncogene
  234. CD34 CD34 molecule
  235. MUC1 mucin 1, cell surface associated
  236. GATA4 GATA binding protein 4
  237. TLR4 toll-like receptor 4
  238. MX1 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)
  239. NR4A1 nuclear receptor subfamily 4, group A, member 1
  240. MITF microphthalmia-associated transcription factor
  241. TXNIP thioredoxin interacting protein
  242. PDCD1 programmed cell death 1
  243. DHDH dihydrodiol dehydrogenase (dimeric)
  244. SPI1 spleen focus forming virus (SFFV) proviral integration oncogene
  245. BIRC3 baculoviral IAP repeat containing 3
  246. PPIA peptidylprolyl isomerase A (cyclophilin A)
  247. CDK4 cyclin-dependent kinase 4
  248. BRD4 bromodomain containing 4
  249. MYD88 myeloid differentiation primary response 88
  250. NLRP3 NLR family, pyrin domain containing 3
  251. LOX lysyl oxidase
  252. IFNG interferon, gamma
  253. CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
  254. RUNX2 runt-related transcription factor 2
  255. CD14 CD14 molecule
  256. IKZF1 IKAROS family zinc finger 1 (Ikaros)
  257. CSF1R colony stimulating factor 1 receptor
  258. RAD51 RAD51 recombinase
  259. HRAS Harvey rat sarcoma viral oncogene homolog
  260. SQSTM1 sequestosome 1
  261. ATRX alpha thalassemia/mental retardation syndrome X-linked
  262. KMT2A lysine (K)-specific methyltransferase 2A
  263. FASN fatty acid synthase
  264. TTR transthyretin
  265. CXXC5 CXXC finger protein 5
  266. POR P450 (cytochrome) oxidoreductase
  267. FOXP3 forkhead box P3
  268. ICAM1 intercellular adhesion molecule 1
  269. ADRB2 adrenoceptor beta 2, surface
  270. MSH2 mutS homolog 2
  271. CTGF connective tissue growth factor
  272. CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit
  273. CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1
  274. ATF3 activating transcription factor 3
  275. SHH sonic hedgehog
  276. SREBF1 sterol regulatory element binding transcription factor 1
  277. TRIM28 tripartite motif containing 28
  278. ADIPOQ adiponectin, C1Q and collagen domain containing
  279. NTRK1 neurotrophic tyrosine kinase, receptor, type 1
  280. NRG1 neuregulin 1
  281. ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
  282. TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box)
  283. PRDM1 PR domain containing 1, with ZNF domain
  284. FBXW7 F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
  285. SMARCB1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
  286. FMR1 fragile X mental retardation 1
  287. COL3A1 collagen, type III, alpha 1
  288. GSTM1 glutathione S-transferase mu 1
  289. MC1R melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
  290. PTPRC protein tyrosine phosphatase, receptor type, C
  291. FGF2 fibroblast growth factor 2 (basic)
  292. PRKCA protein kinase C, alpha
  293. CD68 CD68 molecule
  294. TAS2R38 taste receptor, type 2, member 38
  295. CAT catalase
  296. EEF1A1 eukaryotic translation elongation factor 1 alpha 1
  297. BMP2 bone morphogenetic protein 2
  298. TGFBR1 transforming growth factor, beta receptor 1
  299. XBP1 X-box binding protein 1
  300. TP63 tumor protein p63
  301. LEP leptin
  302. CSF2 colony stimulating factor 2 (granulocyte-macrophage)
  303. ITGB1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
  304. MMP2 matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
  305. HSPA1A heat shock 70kDa protein 1A
  306. PKM pyruvate kinase, muscle
  307. JUP junction plakoglobin
  308. PDK1 pyruvate dehydrogenase kinase, isozyme 1
  309. SPARC secreted protein, acidic, cysteine-rich (osteonectin)
  310. KDM1A lysine (K)-specific demethylase 1A
  311. CAV1 caveolin 1, caveolae protein, 22kDa
  312. PARK2 parkin RBR E3 ubiquitin protein ligase
  313. NKX2-5 NK2 homeobox 5
  314. PGR progesterone receptor
  315. ZEB2 zinc finger E-box binding homeobox 2
  316. NR4A2 nuclear receptor subfamily 4, group A, member 2
  317. TNC tenascin C
  318. IKBKB inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
  319. TGFBR2 transforming growth factor, beta receptor II (70/80kDa)
  320. INSR insulin receptor
  321. CTLA4 cytotoxic T-lymphocyte-associated protein 4
  322. F8 coagulation factor VIII, procoagulant component
  323. CHEK2 checkpoint kinase 2
  324. BCR breakpoint cluster region
  325. SNAI2 snail family zinc finger 2
  326. UTY ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
  327. PECAM1 platelet/endothelial cell adhesion molecule 1
  328. PML promyelocytic leukemia
  329. HMGB1 high mobility group box 1
  330. NQO1 NAD(P)H dehydrogenase, quinone 1
  331. ATF4 activating transcription factor 4
  332. ITGAM integrin, alpha M (complement component 3 receptor 3 subunit)
  333. ACTA1 actin, alpha 1, skeletal muscle
  334. FOXA2 forkhead box A2
  335. HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase
  336. HLA-DRB1 major histocompatibility complex, class II, DR beta 1
  337. CCL5 chemokine (C-C motif) ligand 5
  338. SOX17 SRY (sex determining region Y)-box 17
  339. TFRC transferrin receptor
  340. APOB apolipoprotein B
  341. CDC42 cell division cycle 42
  342. MEF2C myocyte enhancer factor 2C
  343. ARNT aryl hydrocarbon receptor nuclear translocator
  344. MYOD1 myogenic differentiation 1
  345. PTK2 protein tyrosine kinase 2
  346. LPL lipoprotein lipase
  347. KITLG KIT ligand
  348. CLU clusterin
  349. XIAP X-linked inhibitor of apoptosis
  350. EPAS1 endothelial PAS domain protein 1
  351. BMP4 bone morphogenetic protein 4
  352. DKK1 dickkopf WNT signaling pathway inhibitor 1
  353. CD4 CD4 molecule
  354. MECOM MDS1 and EVI1 complex locus
  355. KDM6B lysine (K)-specific demethylase 6B
  356. PROM1 prominin 1
  357. ERG v-ets avian erythroblastosis virus E26 oncogene homolog
  358. FUS fused in sarcoma
  359. GSTP1 glutathione S-transferase pi 1
  360. NKX2-1 NK2 homeobox 1
  361. CSF1 colony stimulating factor 1 (macrophage)
  362. SCN1A sodium channel, voltage-gated, type I, alpha subunit
  363. ATR ataxia telangiectasia and Rad3 related
  364. FRK fyn-related kinase
  365. HDAC1 histone deacetylase 1
  366. THY1 Thy-1 cell surface antigen
  367. AKT3 v-akt murine thymoma viral oncogene homolog 3
  368. HFE hemochromatosis
  369. YY1 YY1 transcription factor
  370. TNFSF10 tumor necrosis factor (ligand) superfamily, member 10
  371. CACNA1A calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
  372. AXL AXL receptor tyrosine kinase
  373. RARA retinoic acid receptor, alpha
  374. ETV1 ets variant 1
  375. SCD stearoyl-CoA desaturase (delta-9-desaturase)
  376. RHOA ras homolog family member A
  377. MAF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
  378. NGFR nerve growth factor receptor
  379. MAPK8 mitogen-activated protein kinase 8
  380. CCND2 cyclin D2
  381. MAP3K1 mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
  382. SYNE1 spectrin repeat containing, nuclear envelope 1
  383. NCAM1 neural cell adhesion molecule 1
  384. EGF epidermal growth factor
  385. PTCH1 patched 1
  386. C3 complement component 3
  387. XIST X inactive specific transcript (non-protein coding)
  388. LRP1 low density lipoprotein receptor-related protein 1
  389. EOMES eomesodermin
  390. GBA glucosidase, beta, acid
  391. PDGFRB platelet-derived growth factor receptor, beta polypeptide
  392. IRX3 iroquois homeobox 3
  393. ACACA acetyl-CoA carboxylase alpha
  394. LDHA lactate dehydrogenase A
  395. DICER1 dicer 1, ribonuclease type III
  396. YBX1 Y box binding protein 1
  397. CD19 CD19 molecule
  398. HMGA2 high mobility group AT-hook 2
  399. CASP3 caspase 3, apoptosis-related cysteine peptidase
  400. MBP myelin basic protein
  401. PPARA peroxisome proliferator-activated receptor alpha
  402. PKD1 polycystic kidney disease 1 (autosomal dominant)
  403. BCL11A B-cell CLL/lymphoma 11A (zinc finger protein)
  404. CDH2 cadherin 2, type 1, N-cadherin (neuronal)
  405. BTK Bruton agammaglobulinemia tyrosine kinase
  406. RORC RAR-related orphan receptor C
  407. KEAP1 kelch-like ECH-associated protein 1
  408. PAH phenylalanine hydroxylase
  409. RPS6KB1 ribosomal protein S6 kinase, 70kDa, polypeptide 1
  410. DHFR dihydrofolate reductase
  411. FOXM1 forkhead box M1
  412. EWSR1 EWS RNA-binding protein 1
  413. GDF15 growth differentiation factor 15
  414. NTRK2 neurotrophic tyrosine kinase, receptor, type 2
  415. PLK1 polo-like kinase 1
  416. SMAD2 SMAD family member 2
  417. HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1
  418. LRRK2 leucine-rich repeat kinase 2
  419. CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
  420. HSPA8 heat shock 70kDa protein 8
  421. MYH9 myosin, heavy chain 9, non-muscle
  422. ERBB3 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3
  423. PTPN11 protein tyrosine phosphatase, non-receptor type 11
  424. MMP1 matrix metallopeptidase 1 (interstitial collagenase)
  425. CUX1 cut-like homeobox 1
  426. FOXA1 forkhead box A1
  427. S100A8 S100 calcium binding protein A8
  428. A2M alpha-2-macroglobulin
  429. VGF VGF nerve growth factor inducible
  430. IL1RN interleukin 1 receptor antagonist
  431. HES1 hes family bHLH transcription factor 1
  432. LIF leukemia inhibitory factor
  433. MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor)
  434. ATXN1 ataxin 1
  435. ENO1 enolase 1, (alpha)
  436. FABP4 fatty acid binding protein 4, adipocyte
  437. HLA-A major histocompatibility complex, class I, A
  438. LCN2 lipocalin 2
  439. DPP4 dipeptidyl-peptidase 4
  440. CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19
  441. MLKL mixed lineage kinase domain-like
  442. TH tyrosine hydroxylase
  443. KDM5B lysine (K)-specific demethylase 5B
  444. HTR2A 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
  445. EDN1 endothelin 1
  446. SGK1 serum/glucocorticoid regulated kinase 1
  447. HBA1 hemoglobin, alpha 1
  448. ANXA2 annexin A2
  449. MALAT1 metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
  450. FGA fibrinogen alpha chain
  451. CHEK1 checkpoint kinase 1
  452. TIMP1 TIMP metallopeptidase inhibitor 1
  453. FAT1 FAT atypical cadherin 1
  454. TEK TEK tyrosine kinase, endothelial
  455. NOD2 nucleotide-binding oligomerization domain containing 2
  456. ARG1 arginase 1
  457. FGR feline Gardner-Rasheed sarcoma viral oncogene homolog
  458. SETD2 SET domain containing 2
  459. PGK1 phosphoglycerate kinase 1
  460. AREG amphiregulin
  461. PAX5 paired box 5
  462. DDIT4 DNA-damage-inducible transcript 4
  463. CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1
  464. CDK2 cyclin-dependent kinase 2
  465. CCNA2 cyclin A2
  466. FLG filaggrin
  467. MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase)
  468. SLC6A3 solute carrier family 6 (neurotransmitter transporter), member 3
  469. IRF1 interferon regulatory factor 1
  470. EPO erythropoietin
  471. ASS1 argininosuccinate synthase 1
  472. CP ceruloplasmin (ferroxidase)
  473. EGR2 early growth response 2
  474. FKBP5 FK506 binding protein 5
  475. PRKAA1 protein kinase, AMP-activated, alpha 1 catalytic subunit
  476. ERBB4 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4
  477. ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2
  478. CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4
  479. BAD BCL2-associated agonist of cell death
  480. DLK1 delta-like 1 homolog (Drosophila)
  481. JAG1 jagged 1
  482. GFAP glial fibrillary acidic protein
  483. GLI1 GLI family zinc finger 1
  484. KL klotho
  485. JARID2 jumonji, AT rich interactive domain 2
  486. ROS1 c-ros oncogene 1 , receptor tyrosine kinase
  487. FGB fibrinogen beta chain
  488. ALDH1A1 aldehyde dehydrogenase 1 family, member A1
  489. CD40 CD40 molecule, TNF receptor superfamily member 5
  490. TSC2 tuberous sclerosis 2
  491. APOA1 apolipoprotein A-I
  492. POSTN periostin, osteoblast specific factor
  493. AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
  494. PDE4DIP phosphodiesterase 4D interacting protein
  495. VCAN versican
  496. IFIT1 interferon-induced protein with tetratricopeptide repeats 1
  497. SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
  498. ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
  499. PARN poly(A)-specific ribonuclease
  500. AHNAK AHNAK nucleoprotein



Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

Version: 3.12.224 13 Oct 2014
hostname: 356980-web2.xennexinc.com index build: 128 solr: 1.4